首页> 美国卫生研究院文献>Stem Cells and Development >The Proper Criteria for Identification and Sorting of Very Small Embryonic-Like Stem Cells and Some Nomenclature Issues
【2h】

The Proper Criteria for Identification and Sorting of Very Small Embryonic-Like Stem Cells and Some Nomenclature Issues

机译:识别和分类非常小的类胚胎干细胞的正确标准以及一些命名问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Evidence has accumulated that both murine and human adult tissues contain early-development stem cells with a broader differentiation potential than other adult monopotent stem cells. These cells, being pluripotent or multipotent, exist at different levels of specification and most likely represent overlapping populations of cells that, depending on the isolation strategy, ex vivo expansion protocol, and markers employed for their identification, have been given different names. In this review, we will discuss a population of very small embryonic-like stem cells (VSELs) in the context of other stem cells that express pluripotent/multipotent markers isolated from adult tissues as well as review the most current, validated working criteria on how to properly identify and isolate these very rare cells. VSELs have been successfully purified in several laboratories; however, a few have failed to isolate them, which has raised some unnecessary controversy in the field. Therefore, in this short review, we will address the most important reasons that some investigators have experienced problems in isolating these very rare cells and discuss some still unresolved challenges which should be overcome before these cells can be widely employed in the clinic.
机译:已有证据表明,鼠类和人类成年组织均含有早期发育的干细胞,其分化潜能比其他成人单能干细胞更大。这些多能或多能细胞以不同的规格水平存在,最有可能代表重叠的细胞群,这些细胞根据分离策略,离体扩增方案和用于鉴定的标记物被赋予不同的名称。在这篇综述中,我们将在其他干细胞的背景下讨论一群非常小的胚胎样干细胞(VSEL),这些干细胞表达从成年组织中分离出的多能/多能标记,并回顾如何验证最新的经验证的工作标准。正确识别和分离这些非常罕见的细胞。 VSEL​​已在多个实验室成功纯化。但是,有一些未能隔离它们,这在该领域引起了一些不必要的争议。因此,在这篇简短的综述中,我们将解决一些研究人员在分离这些非常罕见的细胞时遇到问题的最重要原因,并讨论一些尚待解决的挑战,在将这些细胞广泛应用于临床之前应克服这些挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号